How to Measure DELIVERed Benefits of Dapagliflozin in the Management of HFmrEF/HFpEF?

被引：0
|
作者：
Tanaka, Atsushi [1 ]
Sawami, Kosuke [1 ]
Node, Koichi [1 ]
机构：
[1] Saga Univ, Dept Cardiovasc Med, 5-1-1 Nabeshima, Saga 8498501, Japan
来源：
JACC-HEART FAILURE | 2023年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.jchf.2022.11.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [1] Dapagliflozin improves outcomes in HFmrEF and HFpEF
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2022, 19 : 719 - 719
  • [2] Dapagliflozin improves outcomes in HFmrEF and HFpEF
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (11) : 719 - 719
  • [3] Blood Pressure and Lack of Association With Treatment Benefits of Dapagliflozin in HFpEF and HFmrEF Reply
    Selvaraj, Senthil
    Solomon, Scott D.
    JACC-HEART FAILURE, 2023, 11 (02) : 261 - 261
  • [4] Efficacy and safety of dapagliflozin in the background of polypharmacy among patients with HFmrEF and HFpEF in the DELIVER trial
    Peikert
    Goyal, P.
    Vaduganathan, M.
    Claggett, B. L.
    Desai, A. S.
    Jhund, P. S.
    Kosiborod, M. N.
    Lam, C. S. P.
    Inzucchi, S. E.
    A Martinez, F.
    De Boer, R. A.
    Hernandez, A. F.
    Shah, S. J.
    Mcmurray, J. J. V.
    Solomon, S. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 196 - 197
  • [5] Real-world clinical characteristics and eligibility for dapagliflozin in HFmrEF and HFpEF patients: data from a Belgian tertiary HF center
    Bogaerts, Eline
    Beles, Monika
    Masuy, Imke
    Verstreken, Sofie
    Heggermont, Ward
    Bartunek, Jozef
    Dierckx, Riet
    Goethals, Marc
    De Boeck, Marieke
    Fovel, Isabelle
    Vermeulen, Zarha
    Maris, Michael
    Vanderheyden, Marc
    ACTA CARDIOLOGICA, 2023, 78 : 11 - 11
  • [6] Projected lifetime benefits of sacubitril/valsartan on event-free survival in patients with HFmrEF and HFpEF in the PARAGON-HF trial
    Foa, A. Alberto
    Claggett, B. L.
    Miao, M.
    Pabon, M.
    Lu, H.
    Pfeffer, M. A.
    Packer, M.
    Rouleau, J. L.
    Lefkowitz, M.
    Desai, A. S.
    Mcmurray, J. J. V.
    Solomon, S. D.
    Vaduganathan, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 225 - 226
  • [7] Litigation benefits state-delivered medicine - but for how long?
    Bateman, Chris
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2015, 105 (01): : 13 - 14
  • [8] How to measure the benefits of BIM - A case study approach
    Barlish, Kristen
    Sullivan, Kenneth
    AUTOMATION IN CONSTRUCTION, 2012, 24 : 149 - 159
  • [9] How to Measure Benefits of Non-standard Healthcare Systems
    Kunstova, Renata
    Potancok, Martin
    INZINERINE EKONOMIKA-ENGINEERING ECONOMICS, 2013, 24 (02): : 119 - 125
  • [10] How To Measure the Outcomes of Chronic Disease Management
    Lewis, Al
    POPULATION HEALTH MANAGEMENT, 2009, 12 (01) : 47 - 54
12345